CS
LLY icon

Credit Suisse’s Eli Lilly LLY Stock Holding History

Credit Suisse’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-144,500
Closed -$39.9M – 4007
2021
Q4 		$39.9M Sell
144,500
-44,100
-23% -$11.2M 0.02% 747
2021
Q3 		$43.6M Sell
188,600
-3,800
-2% -$938K 0.02% 695
2021
Q2 		$44.1M Buy
192,400
+33,700
+21% +$6.77M 0.02% 758
2021
Q1 		$29.6M Buy
158,700
+90,700
+133% +$17.7M 0.02% 962
2020
Q4 		$11.5M Sell
68,000
-29,600
-30% -$4.42M 0.01% 1490
2020
Q3 		$14.4M Buy
97,600
+13,900
+17% +$2.15M 0.01% 1180
2020
Q2 		$13.7M Buy
83,700
+58,200
+228% +$8.93M 0.01% 1135
2020
Q1 		$3.54M Sell
25,500
-31,200
-55% -$4.29M ﹤0.01% 1754
2019
Q4 		$7.45M Hold
56,700
– – 0.01% 1591
2019
Q3 		$6.34M Sell
56,700
-12,600
-18% -$1.4M 0.01% 1583
2019
Q2 		$7.68M Sell
69,300
-70,400
-50% -$8.29M 0.01% 1473
2019
Q1 		$18.1M Sell
139,700
-188,800
-57% -$23M 0.02% 919
2018
Q4 		$38M Sell
328,500
-133,900
-29% -$15M 0.04% 482
2018
Q3 		$49.6M Buy
462,400
+291,700
+171% +$29.2M 0.04% 427
2018
Q2 		$14.6M Buy
170,700
+50,000
+41% +$4.11M 0.01% 1025
2018
Q1 		$9.34M Buy
120,700
+70,700
+141% +$5.69M 0.01% 1276
2017
Q4 		$4.22M Hold
50,000
– – ﹤0.01% 1888
2017
Q3 		$4.28M Buy
+50,000
New +$4.1M ﹤0.01% 1894
2017
Q2 		– Sell
-60,000
Closed -$5.05M – 3900
2017
Q1 		$5.05M Buy
60,000
+10,000
+20% +$801K ﹤0.01% 1650
2016
Q4 		$3.68M Sell
50,000
-80,000
-62% -$5.96M ﹤0.01% 1895
2016
Q3 		$10.4M Buy
130,000
+50,000
+63% +$4M 0.01% 1158
2016
Q2 		$6.3M Buy
+80,000
New +$6.02M 0.01% 1476
2014
Q4 		– Sell
-1,430,100
Closed -$92.7M – 4665
2014
Q3 		$92.7M Sell
1,430,100
-500,000
-26% -$31.7M 0.08% 258
2014
Q2 		$120M Buy
1,930,100
+1,417,200
+276% +$84.6M 0.1% 195
2014
Q1 		$30.2M Buy
+512,900
New +$28.6M 0.03% 636

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Credit Suisse's LLY Position: Q1 2024 in Review

Credit Suisse increased its Eli Lilly (LLY) stake by 4.5% in Q1 2024, buying an estimated $48.5M and bringing the position to 1,584,543 shares worth $1.23B. The position accounts for 1.18% of the portfolio, ranked #11.

Credit Suisse first reported a position in LLY in Q2 2013 and has held it in 44 quarters since. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Credit Suisse held 1,584,543 shares of Eli Lilly worth $1.23B as of Q1 2024.
  • Credit Suisse bought 68,198 Eli Lilly shares in Q1 2024, an estimated $48.5M.
  • Eli Lilly made up 1.18% of Credit Suisse's portfolio in Q1 2024, its #11 holding.
  • Credit Suisse first reported a position in Eli Lilly in Q2 2013 and has held it in 44 quarters since.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.